Seven new members were voted onto the BioForward board of directors, the organization announced recently.

Serving a 2020-21 term from Madison are Exact Sciences Vice President of Operations Tammy Turek-Etienne, Eurofins-Madison General Manager and Vice President of Chemistry Operations Edward Ladwig, Promega Director of Strategic Portfolio Management Janet White and Morgridge Institute for Research CEO Brad Schwartz.

“Our new board members bring leadership and expertise from all corners of the vast biohealth industry, offering insight and a huge potential for growth in 2020 for both our industry and our state,” BioForward CEO Lisa Johnson said in a statement.

According to a release, the new members will join 11 current board members, all of whom represent the many facets of the state’s diverse biohealth industry.